CY2444B1 - Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs. - Google Patents

Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs.

Info

Publication number: CY2444B1
Authority: CY; Cyprus
Prior art keywords: vitamin; tpgs; compositions; compound; water soluble
Prior art date: 1996-03-22

Application number

CY0400050A

Other languages

English (en)

Inventor

Arup K Roy

Lloyd Gary Tillman

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-22

Filing date

2004-06-23

Publication date

2004-11-12

1996-03-26 Priority claimed from GBGB9606372.2A external-priority patent/GB9606372D0/en

1997-03-20 Priority claimed from US08/820,848 external-priority patent/US6730679B1/en

2004-06-23 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2004-11-12 Publication of CY2444B1 publication Critical patent/CY2444B1/xx

Links

229940122440 HIV protease inhibitor Drugs 0.000 title 1
AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000004030 hiv protease inhibitor Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229940088594 vitamin Drugs 0.000 title 1
229930003231 vitamin Natural products 0.000 title 1
235000013343 vitamin Nutrition 0.000 title 1
239000011782 vitamin Substances 0.000 title 1
150000003722 vitamin derivatives Chemical class 0.000 title 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

CY0400050A 1996-03-22 2004-06-23 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs. CY2444B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1389396P	1996-03-22	1996-03-22
GBGB9606372.2A GB9606372D0 (en)	1996-03-26	1996-03-26	Pharmaceutical formulations
US08/820,848 US6730679B1 (en)	1996-03-22	1997-03-20	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
CY2444B1 true CY2444B1 (en)	2004-11-12

Family

ID=27268205

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY0400050A CY2444B1 (en)	1996-03-22	2004-06-23	Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs.

Country Status (23)

Country	Link
EP (1)	EP0906107B1 (cs)
CN (1)	CN1225587A (cs)
AP (1)	AP1150A (cs)
AT (1)	ATE230602T1 (cs)
AU (1)	AU724239B2 (cs)
BR (1)	BR9708238A (cs)
CA (1)	CA2249336C (cs)
CY (1)	CY2444B1 (cs)
CZ (1)	CZ289958B6 (cs)
DE (1)	DE69718315T2 (cs)
DK (1)	DK0906107T3 (cs)
EA (1)	EA001484B1 (cs)
EE (1)	EE04093B1 (cs)
ES (1)	ES2190528T3 (cs)
GE (1)	GEP20012464B (cs)
IS (1)	IS2066B (cs)
NO (1)	NO317639B1 (cs)
NZ (1)	NZ331645A (cs)
RO (1)	RO119923B1 (cs)
SI (1)	SI0906107T1 (cs)
SK (1)	SK284244B6 (cs)
TR (1)	TR199801881T2 (cs)
UY (1)	UY25926A1 (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN114366808B (zh) *	2021-12-14	2023-10-13	南京农业大学	一种多糖和病毒抗原共递送纳米疫苗、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IS2334B (is) *	1992-09-08	2008-02-15	Vertex Pharmaceuticals Inc., (A Massachusetts Corporation)	Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
GB9409778D0 (en) *	1994-05-16	1994-07-06	Dumex Ltd As	Compositions
JPH11505257A (ja) *	1995-05-19	1999-05-18	アボツト・ラボラトリーズ	親油性薬物の自己乳化性製剤

1997
- 1997-03-21 BR BR9708238A patent/BR9708238A/pt not_active IP Right Cessation
- 1997-03-21 AP APAP/P/1998/001343A patent/AP1150A/en active
- 1997-03-21 EA EA199800755A patent/EA001484B1/ru not_active IP Right Cessation
- 1997-03-21 ES ES97914287T patent/ES2190528T3/es not_active Expired - Lifetime
- 1997-03-21 AU AU21591/97A patent/AU724239B2/en not_active Expired
- 1997-03-21 SI SI9730498T patent/SI0906107T1/xx unknown
- 1997-03-21 SK SK1269-98A patent/SK284244B6/sk not_active IP Right Cessation
- 1997-03-21 CZ CZ19983035A patent/CZ289958B6/cs not_active IP Right Cessation
- 1997-03-21 EE EE9800323A patent/EE04093B1/xx unknown
- 1997-03-21 TR TR1998/01881T patent/TR199801881T2/xx unknown
- 1997-03-21 DE DE69718315T patent/DE69718315T2/de not_active Expired - Lifetime
- 1997-03-21 GE GEAP19974496A patent/GEP20012464B/en unknown
- 1997-03-21 DK DK97914287T patent/DK0906107T3/da active
- 1997-03-21 NZ NZ331645A patent/NZ331645A/en not_active IP Right Cessation
- 1997-03-21 RO RO98-01407A patent/RO119923B1/ro unknown
- 1997-03-21 AT AT97914287T patent/ATE230602T1/de active
- 1997-03-21 EP EP97914287A patent/EP0906107B1/en not_active Expired - Lifetime
- 1997-03-21 CN CN97193229A patent/CN1225587A/zh active Pending
- 1997-03-21 CA CA002249336A patent/CA2249336C/en not_active Expired - Lifetime
1998
- 1998-08-28 IS IS4840A patent/IS2066B/xx unknown
- 1998-09-21 NO NO19984386A patent/NO317639B1/no not_active IP Right Cessation
2000
- 2000-01-17 UY UY25926A patent/UY25926A1/es not_active Application Discontinuation
2004
- 2004-06-23 CY CY0400050A patent/CY2444B1/xx unknown

Also Published As

Publication number	Publication date
TR199801881T2 (xx)	1999-01-18
SK126998A3 (en)	1999-10-08
NO984386L (no)	1998-11-20
BR9708238A (pt)	1999-08-03
EE04093B1 (et)	2003-08-15
AU2159197A (en)	1997-10-17
NO317639B1 (no)	2004-11-29
SI0906107T1 (en)	2003-08-31
CA2249336C (en)	2005-11-22
DE69718315D1 (de)	2003-02-13
DK0906107T3 (da)	2003-05-05
CZ303598A3 (cs)	1999-03-17
GEP20012464B (en)	2001-06-25
AP1150A (en)	2003-03-14
UY25926A1 (es)	2000-09-29
IS2066B (is)	2005-11-15
EA199800755A1 (ru)	1999-06-24
CZ289958B6 (cs)	2002-05-15
AU724239B2 (en)	2000-09-14
EP0906107A1 (en)	1999-04-07
NO984386D0 (no)	1998-09-21
RO119923B1 (ro)	2005-06-30
CN1225587A (zh)	1999-08-11
DE69718315T2 (de)	2003-10-30
IS4840A (is)	1998-08-28
HK1016896A1 (en)	1999-11-12
ATE230602T1 (de)	2003-01-15
EP0906107B1 (en)	2003-01-08
SK284244B6 (sk)	2004-12-01
NZ331645A (en)	2000-02-28
CA2249336A1 (en)	1997-10-02
ES2190528T3 (es)	2003-08-01
AP9801343A0 (en)	1998-09-30
EA001484B1 (ru)	2001-04-23
EE9800323A (et)	1999-04-15

Publication	Publication Date	Title
IL110752A0 (en)	1994-11-28	Pharmaceutical composition for an hiv protease inhibitor
HU0900219D0 (en)	2009-06-29	Hiv protease inhibitor
EP0621279A3 (en)	1995-01-04	Siloxy-aluminoxane compositions.
HUP0104768A3 (en)	2002-05-28	4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
HUP0103806A3 (en)	2002-03-28	Serine protease inhibitor and pharmaceutical compositions containing them
FI961097L (fi)	1996-03-08	Hapettumisenkestäviä proteaaseja
IL126185A0 (en)	1999-05-09	Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
HUP0201591A3 (en)	2002-10-28	Pharmaceutical formulations comprising an hiv protease inhibitor
ZA977104B (en)	1998-02-18	Pharmaceutical compositions.
ZA949151B (en)	1995-07-29	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents.
EP0691345A3 (en)	1996-02-28	Combinations of HIV protease inhibitors
ZA947775B (en)	1995-05-17	Water-soluble retinoids.
GB9422918D0 (en)	1995-01-04	Concentrated surfactant compositions
CY2444B1 (en)	2004-11-12	Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs.
ZA972602B (en)	1997-09-29	Pharmaceutical compositions.
CY2411B1 (en)	2004-11-12	Compositions.
ZA989644B (en)	2000-04-25	Insoluble insulen compositions.
AU7689798A (en)	1998-12-11	Vif-derived hiv protease inhibitors
ZA974422B (en)	1997-12-22	Substituted-amidinobenzene derivative and pharmaceutical compositions thereof.
GB9309475D0 (en)	1993-06-23	Concentrated aqueous based surfactant compositions
MXPA99008395A (es)	2003-08-12	Inhibidores de la proteasa del vih.
AU2480095A (en)	1996-01-18	HIV protease inhibitor combinations
HK1026891A (zh)	2000-12-29	Hiv蛋白酶抑制剂
SG49247A1 (en)	1998-05-18	Hiv protease inhibitors
ZA982367B (en)	1999-09-20	Pharmaceutical compositions.